-
Leslie S. Zun, MD, chairman of the department of emergency medicine at Rosalind Franklin University of Medicine and Science in North Chicago, IL, says that if a patient discharged from the ED later commits suicide, "there are a number of issues that can place the emergency physician at risk." Zun gives these five major areas of risk involving ED psychiatric patients:
-
A 25-year-old male patient is brought to an ED because of suicidal statements made to his ex-wife. The patient arrives via police escort and is placed in a room. The ED nurse assesses the patient, who denies suicidal ideation or intent. Although the man admits to drinking alcohol, he does not appear to be overtly intoxicated and is coherent. The ED is extremely busy, and the physician assistant (PA) picks up the chart.
-
Michigan appeals court allows use of hospital's internal policies and ACEP's Clinical Chest Pain policy as evidence against hospital and urgent care physician in malpractice case.
-
Obtaining accurate, detailed information about a patient's insurance coverage is the goal of any registrar, regardless of the patient's point of entry. Clearly, though, emergency department (ED) patients pose some unique challenges.
-
As payer requirements become more numerous and stringent, any type of error can result in a needless claims denial.
-
The mission of eight onsite Medicaid case managers at WakeMed Health & Hospitals in Raleigh, NC, is to "focus only on patients who have been patients at WakeMed," says Heidi McAfee, director of patient access/case management.
-
WakeMed Health & Hospitals in Raleigh, NC, has a long history of caring for all who seek service regardless of the ability to pay, and is currently facing a marked increase in uninsured patients.
-
A nationwide survey conducted in March 2008 of 429 pediatricians and 419 family physicians in the United States with response rates of 81% and 79%, respectively, showed that 98% of pediatricians and 80% of family physicians were administering HPV vaccine in their offices.
-
Lorcaserin submitted for FDA review, FDA advisory panel votes against phentermine/topiramate, mixed vote on rosiglitazone, advisory panel votes to remove breast cancer indication from bevacizumab labeling, no increase in seizures found with DTaP vaccine, new REMS for quinine.
-
